社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
haihaidong
IP属地：河北
+关注
帖子 · 14
帖子 · 14
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
haihaidong
haihaidong
·
2024-06-19
竞猜赢虎币 ，寻找实盘收益王
查看详情：
竞猜赢虎币 ，寻找实盘收益王
快来参与实盘竞猜活动，寻找你心中的收益王者，竞猜最高可获得USD 500代金券奖励。 此帖仅开放于中国大陆用户
看
1,112
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
竞猜赢虎币 ，寻找实盘收益王
haihaidong
haihaidong
·
2024-05-11
基因武器[喷血] [生病] [梭哈] [默哀]
诺瓦瓦克斯医药与赛诺菲就新冠疫苗达成数十亿美元合作
5月10日，$诺瓦瓦克斯医药$周五宣布，与法国制药巨头$赛诺菲$达成了一项价值数十亿美元的合作协议。此外，诺瓦瓦克斯医药还将从赛诺菲销售的新冠疫苗以及针对冠状病毒和流感的组合疫苗中获得特许权使用费。根据协议条款，诺瓦瓦克斯医药将在今年剩余时间内主导其新冠疫苗的商业化，并计划于2025年将大部分责任移交给赛诺菲。
诺瓦瓦克斯医药与赛诺菲就新冠疫苗达成数十亿美元合作
看
742
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2023-11-24
红包拿来，天天开心！
看
1,471
回复
评论
点赞
2
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2023-11-24
感恩的心，感谢有你，感恩每一个陪伴的你我他！
看
1,231
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2023-03-30
华为一冒头，立刻就要按回去，真真切切实实在在的全维度打压。呵呵！
非常抱歉，此主贴已删除
看
1,859
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2023-02-09
分析全面中肯[爱你] [强] [比心] [爱心] [看涨] [梭哈]
非常抱歉，此主贴已删除
看
2,214
回复
评论
点赞
1
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2022-12-22
一头雾水
非常抱歉，此主贴已删除
看
2,289
回复
评论
点赞
1
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2022-12-20
回顾2022年的投资记录，感慨万千，多少不眠之夜，多少目瞪口呆，多少心神恍惚，多少心酸悔恨，多少失望又多少希望，多少坎坷又多少期盼，黑暗交替光明，失落伴随信心，相知在今朝，相信在明天，相守在今虎，相爱在明兔，心在2022，爱在2023！
看
2,834
回复
6
点赞
8
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2021-09-04
小米不抢怎能无敌天下！一定要加强的加枪￥
小米公关总经理回应雷军“减持3亿股”：系可统计份额降低
小米集团公关部总经理王化就雷军今日卖出逾3亿股小米股份，通过其个人微博回应称：“雷军不再控制雷军基金会导致可统计份额降低，并非减持，这家基金会是一家具有公共性质的慈善机构，而雷军根据香港当地条例终止对
小米公关总经理回应雷军“减持3亿股”：系可统计份额降低
看
1,751
回复
评论
点赞
1
编组 21备份 2
分享
举报
haihaidong
haihaidong
·
2021-09-04
虚拟现实 元宇宙 全真教教主
非常抱歉，此主贴已删除
看
3,207
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581646110825350","uuid":"3581646110825350","gmtCreate":1618753271999,"gmtModify":1624440921638,"name":"haihaidong","pinyin":"haihaidong","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":414,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":47,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":283,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.06","exceedPercentage":"80.32%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"河北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":33,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":318271204765888,"gmtCreate":1718741473720,"gmtModify":1718746520908,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"title":"竞猜赢虎币 ，寻找实盘收益王","htmlText":"查看详情：<a href=\"https://tigr.link/8yaDaS\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与实盘竞猜活动，寻找你心中的收益王者，竞猜最高可获得USD 500代金券奖励。 此帖仅开放于中国大陆用户","listText":"查看详情：<a href=\"https://tigr.link/8yaDaS\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与实盘竞猜活动，寻找你心中的收益王者，竞猜最高可获得USD 500代金券奖励。 此帖仅开放于中国大陆用户","text":"查看详情：竞猜赢虎币 ，寻找实盘收益王 快来参与实盘竞猜活动，寻找你心中的收益王者，竞猜最高可获得USD 500代金券奖励。 此帖仅开放于中国大陆用户","images":[{"img":"https://static.tigerbbs.com/f22c491ee8ae08f0d36ded0795f1fe33"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/318271204765888","isVote":1,"tweetType":1,"viewCount":1112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":304531226423488,"gmtCreate":1715383086154,"gmtModify":1715383088186,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"基因武器[喷血] [生病] [梭哈] [默哀] ","listText":"基因武器[喷血] [生病] [梭哈] [默哀] ","text":"基因武器[喷血] [生病] [梭哈] [默哀]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/304531226423488","repostId":"2434188644","repostType":2,"repost":{"id":"2434188644","kind":"news","pubTimestamp":1715325808,"share":"https://www.laohu8.com/m/news/2434188644?lang=&edition=full","pubTime":"2024-05-10 15:23","market":"us","language":"zh","title":"诺瓦瓦克斯医药与赛诺菲就新冠疫苗达成数十亿美元合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2434188644","media":"智通财经","summary":"5月10日，$诺瓦瓦克斯医药$周五宣布，与法国制药巨头$赛诺菲$达成了一项价值数十亿美元的合作协议。此外，诺瓦瓦克斯医药还将从赛诺菲销售的新冠疫苗以及针对冠状病毒和流感的组合疫苗中获得特许权使用费。根据协议条款，诺瓦瓦克斯医药将在今年剩余时间内主导其新冠疫苗的商业化，并计划于2025年将大部分责任移交给赛诺菲。","content":"<html><head></head><body><p>5月10日，<strong><a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯医药</a>盘前暴涨到停不下来，截至发稿涨幅超200%！</strong>诺瓦瓦克斯医药周五宣布，与法国制药巨头<a href=\"https://laohu8.com/S/SNY\">赛诺菲</a>达成了一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bcbbd094d7336d45ddf2c7feeb823779\" title=\"\" tg-width=\"450\" tg-height=\"126\"/></p><p>诺瓦瓦克斯医药首席执行官约翰·雅各布斯(John Jacobs)表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告，该警告是由于市场对其持续运营能力存疑而于2023年2月首次发布的。</p><p>对于这家一直在努力的疫苗制造商来说，此次合作标志着一个重要的转折点，其基于蛋白质的新冠疫苗被卫生官员视为对那些不愿接种信使RNA疫苗人群的宝贵替代选择。</p><p>在该合作协议中，赛诺菲将利用诺瓦瓦克斯医药的新冠疫苗和旗舰疫苗技术Matrix-M佐剂来开发新的疫苗产品。作为交易的一部分，赛诺菲将向诺瓦瓦克斯医药支付5亿美元的预付款，并在达成开发、监管和上市里程碑时支付高达7亿美元的额外款项。这笔交易的总价值大约是诺瓦瓦克斯医药目前市值的两倍。</p><p>此外，诺瓦瓦克斯医药还将从赛诺菲销售的新冠疫苗以及针对冠状病毒和流感的组合疫苗中获得特许权使用费。对于赛诺菲使用Matrix-M佐剂开发的每种产品，诺瓦瓦克斯医药还有权获得高达2亿美元的额外启动和销售里程碑付款以及特许权使用费。赛诺菲还将持有诺瓦瓦克斯医药不到5%的股份。</p><p>雅各布斯表示，这项交易将为诺瓦瓦克斯医药带来充足的资本，使其能够持续经营，并有机会将战略更多地转向其最擅长的领域，为所有利益相关者，包括股东，创造更多价值。</p><p>此外，该交易还将支持公司实现其疫苗技术平台改善全球公共卫生的使命，这是单凭公司自身资源难以实现的。</p><p>根据协议条款，诺瓦瓦克斯医药将在今年剩余时间内主导其新冠疫苗的商业化，并计划于2025年将大部分责任移交给赛诺菲。赛诺菲不会参与监督与诺瓦瓦克斯医药现有合作协议的国家的商业化，这些国家包括印度、日本和韩国，以及与该公司签订了新冠疫苗购买协议的国家。</p><p>雅各布斯认为，赛诺菲作为一家大型制药公司，其参与将增加诺瓦瓦克斯医药新冠疫苗的市场份额和可见度，从而扩大患者获取疫苗的机会。此外，赛诺菲还将负责开发和商业化任何包含其流感疫苗和诺瓦瓦克斯医药新冠疫苗的组合产品。</p><p>雅各布斯强调：“通过与赛诺菲这样的全球领先企业合作，我们相信这将大大增加我们更快推出多种新疫苗的机会。”</p><p>除了合作协议，诺瓦瓦克斯医药还计划在今年晚些时候启动针对新冠病毒和流感的联合疫苗以及独立流感疫苗的后期试验。</p><p>此前，公司曾表示试验将仅包括联合疫苗。雅各布斯表示，如果试验成功，公司将不仅拥有一种潜在的可许可疫苗，而且还将开辟自身的有机产品线。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺瓦瓦克斯医药与赛诺菲就新冠疫苗达成数十亿美元合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺瓦瓦克斯医药与赛诺菲就新冠疫苗达成数十亿美元合作\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-10 15:23 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/1119740.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月10日，诺瓦瓦克斯医药盘前暴涨到停不下来，截至发稿涨幅超200%！诺瓦瓦克斯医药周五宣布，与法国制药巨头赛诺菲达成了一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯医药首席执行官约翰·雅各布斯(John Jacobs)表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告，该警告是由于市场对其...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1119740.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","relate_stocks":{"SNY":"赛诺菲安万特","NVAX":"诺瓦瓦克斯医药"},"source_url":"http://www.zhitongcaijing.com/content/detail/1119740.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2434188644","content_text":"5月10日，诺瓦瓦克斯医药盘前暴涨到停不下来，截至发稿涨幅超200%！诺瓦瓦克斯医药周五宣布，与法国制药巨头赛诺菲达成了一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯医药首席执行官约翰·雅各布斯(John Jacobs)表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告，该警告是由于市场对其持续运营能力存疑而于2023年2月首次发布的。对于这家一直在努力的疫苗制造商来说，此次合作标志着一个重要的转折点，其基于蛋白质的新冠疫苗被卫生官员视为对那些不愿接种信使RNA疫苗人群的宝贵替代选择。在该合作协议中，赛诺菲将利用诺瓦瓦克斯医药的新冠疫苗和旗舰疫苗技术Matrix-M佐剂来开发新的疫苗产品。作为交易的一部分，赛诺菲将向诺瓦瓦克斯医药支付5亿美元的预付款，并在达成开发、监管和上市里程碑时支付高达7亿美元的额外款项。这笔交易的总价值大约是诺瓦瓦克斯医药目前市值的两倍。此外，诺瓦瓦克斯医药还将从赛诺菲销售的新冠疫苗以及针对冠状病毒和流感的组合疫苗中获得特许权使用费。对于赛诺菲使用Matrix-M佐剂开发的每种产品，诺瓦瓦克斯医药还有权获得高达2亿美元的额外启动和销售里程碑付款以及特许权使用费。赛诺菲还将持有诺瓦瓦克斯医药不到5%的股份。雅各布斯表示，这项交易将为诺瓦瓦克斯医药带来充足的资本，使其能够持续经营，并有机会将战略更多地转向其最擅长的领域，为所有利益相关者，包括股东，创造更多价值。此外，该交易还将支持公司实现其疫苗技术平台改善全球公共卫生的使命，这是单凭公司自身资源难以实现的。根据协议条款，诺瓦瓦克斯医药将在今年剩余时间内主导其新冠疫苗的商业化，并计划于2025年将大部分责任移交给赛诺菲。赛诺菲不会参与监督与诺瓦瓦克斯医药现有合作协议的国家的商业化，这些国家包括印度、日本和韩国，以及与该公司签订了新冠疫苗购买协议的国家。雅各布斯认为，赛诺菲作为一家大型制药公司，其参与将增加诺瓦瓦克斯医药新冠疫苗的市场份额和可见度，从而扩大患者获取疫苗的机会。此外，赛诺菲还将负责开发和商业化任何包含其流感疫苗和诺瓦瓦克斯医药新冠疫苗的组合产品。雅各布斯强调：“通过与赛诺菲这样的全球领先企业合作，我们相信这将大大增加我们更快推出多种新疫苗的机会。”除了合作协议，诺瓦瓦克斯医药还计划在今年晚些时候启动针对新冠病毒和流感的联合疫苗以及独立流感疫苗的后期试验。此前，公司曾表示试验将仅包括联合疫苗。雅各布斯表示，如果试验成功，公司将不仅拥有一种潜在的可许可疫苗，而且还将开辟自身的有机产品线。","news_type":1},"isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":244772219683040,"gmtCreate":1700773389485,"gmtModify":1700773391846,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"红包拿来，天天开心！","listText":"红包拿来，天天开心！","text":"红包拿来，天天开心！","images":[{"img":"https://static.tigerbbs.com/642171a1be7d77665103e83197be9c9f","width":"1080","height":"2160"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/244772219683040","isVote":1,"tweetType":1,"viewCount":1471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":244767905665208,"gmtCreate":1700772335310,"gmtModify":1700772338157,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"感恩的心，感谢有你，感恩每一个陪伴的你我他！","listText":"感恩的心，感谢有你，感恩每一个陪伴的你我他！","text":"感恩的心，感谢有你，感恩每一个陪伴的你我他！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/244767905665208","isVote":1,"tweetType":1,"viewCount":1231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":659558486,"gmtCreate":1680158863445,"gmtModify":1680158865145,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"华为一冒头，立刻就要按回去，真真切切实实在在的全维度打压。呵呵！","listText":"华为一冒头，立刻就要按回去，真真切切实实在在的全维度打压。呵呵！","text":"华为一冒头，立刻就要按回去，真真切切实实在在的全维度打压。呵呵！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/659558486","repostId":"2323775797","repostType":2,"isVote":1,"tweetType":1,"viewCount":1859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":622720398,"gmtCreate":1675897107014,"gmtModify":1675897109223,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"分析全面中肯[爱你] [强] [比心] [爱心] [看涨] [梭哈] ","listText":"分析全面中肯[爱你] [强] [比心] [爱心] [看涨] [梭哈] ","text":"分析全面中肯[爱你] [强] [比心] [爱心] [看涨] [梭哈]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/622720398","repostId":"1105557454","repostType":2,"isVote":1,"tweetType":1,"viewCount":2214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":621039031,"gmtCreate":1671724108723,"gmtModify":1671724110433,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"一头雾水","listText":"一头雾水","text":"一头雾水","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/621039031","repostId":"2293557321","repostType":2,"isVote":1,"tweetType":1,"viewCount":2289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":623247352,"gmtCreate":1671477642177,"gmtModify":1671477644669,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"回顾2022年的投资记录，感慨万千，多少不眠之夜，多少目瞪口呆，多少心神恍惚，多少心酸悔恨，多少失望又多少希望，多少坎坷又多少期盼，黑暗交替光明，失落伴随信心，相知在今朝，相信在明天，相守在今虎，相爱在明兔，心在2022，爱在2023！","listText":"回顾2022年的投资记录，感慨万千，多少不眠之夜，多少目瞪口呆，多少心神恍惚，多少心酸悔恨，多少失望又多少希望，多少坎坷又多少期盼，黑暗交替光明，失落伴随信心，相知在今朝，相信在明天，相守在今虎，相爱在明兔，心在2022，爱在2023！","text":"回顾2022年的投资记录，感慨万千，多少不眠之夜，多少目瞪口呆，多少心神恍惚，多少心酸悔恨，多少失望又多少希望，多少坎坷又多少期盼，黑暗交替光明，失落伴随信心，相知在今朝，相信在明天，相守在今虎，相爱在明兔，心在2022，爱在2023！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/623247352","isVote":1,"tweetType":1,"viewCount":2834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815568184,"gmtCreate":1630698210748,"gmtModify":1630698210748,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"小米不抢怎能无敌天下！一定要加强的加枪￥","listText":"小米不抢怎能无敌天下！一定要加强的加枪￥","text":"小米不抢怎能无敌天下！一定要加强的加枪￥","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815568184","repostId":"1189577781","repostType":2,"repost":{"id":"1189577781","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630666943,"share":"https://www.laohu8.com/m/news/1189577781?lang=&edition=full","pubTime":"2021-09-03 19:02","market":"hk","language":"zh","title":"小米公关总经理回应雷军“减持3亿股”：系可统计份额降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1189577781","media":"老虎资讯综合","summary":"小米集团公关部总经理王化就雷军今日卖出逾3亿股小米股份，通过其个人微博回应称：“雷军不再控制雷军基金会导致可统计份额降低，并非减持，这家基金会是一家具有公共性质的慈善机构，而雷军根据香港当地条例终止对","content":"<p>小米集团公关部总经理王化就雷军今日卖出逾3亿股小米股份，通过其个人微博回应称：“雷军不再控制雷军基金会导致可统计份额降低，并非减持，这家基金会是一家具有公共性质的慈善机构，而雷军根据香港当地条例终止对基金会的控制”。据小米集团7月16日发布的一则公告，雷军将总计约6.16亿B类小米集团股份，捐赠给了小米基金会和雷军基金会，两家基金会各自获得3.08亿股份，这笔款项将用于公益项目。</p>\n<p><img src=\"https://static.tigerbbs.com/adacf20bb76f3874c835995c0109d35a\" tg-width=\"881\" tg-height=\"727\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>小米公关总经理回应雷军“减持3亿股”：系可统计份额降低</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n小米公关总经理回应雷军“减持3亿股”：系可统计份额降低\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-09-03 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>小米集团公关部总经理王化就雷军今日卖出逾3亿股小米股份，通过其个人微博回应称：“雷军不再控制雷军基金会导致可统计份额降低，并非减持，这家基金会是一家具有公共性质的慈善机构，而雷军根据香港当地条例终止对基金会的控制”。据小米集团7月16日发布的一则公告，雷军将总计约6.16亿B类小米集团股份，捐赠给了小米基金会和雷军基金会，两家基金会各自获得3.08亿股份，这笔款项将用于公益项目。</p>\n<p><img src=\"https://static.tigerbbs.com/adacf20bb76f3874c835995c0109d35a\" tg-width=\"881\" tg-height=\"727\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/aea2b9ab8a046974039715aed46d9985","relate_stocks":{"01810":"小米集团-W"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189577781","content_text":"小米集团公关部总经理王化就雷军今日卖出逾3亿股小米股份，通过其个人微博回应称：“雷军不再控制雷军基金会导致可统计份额降低，并非减持，这家基金会是一家具有公共性质的慈善机构，而雷军根据香港当地条例终止对基金会的控制”。据小米集团7月16日发布的一则公告，雷军将总计约6.16亿B类小米集团股份，捐赠给了小米基金会和雷军基金会，两家基金会各自获得3.08亿股份，这笔款项将用于公益项目。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1751,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815561850,"gmtCreate":1630697863070,"gmtModify":1630697863070,"author":{"id":"3581646110825350","authorId":"3581646110825350","name":"haihaidong","avatar":"https://static.tigerbbs.com/d39e839ab1c6be445345eaa8b4a8ba03","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581646110825350","authorIdStr":"3581646110825350"},"themes":[],"htmlText":"虚拟现实 元宇宙 全真教教主","listText":"虚拟现实 元宇宙 全真教教主","text":"虚拟现实 元宇宙 全真教教主","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815561850","repostId":"2164187883","repostType":2,"isVote":1,"tweetType":1,"viewCount":3207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}